Brief: IN8bio Continues to Build on its Clinical and Regulatory Team with Two Key Appointments
13/04/2022 13:40
April 13 (Reuters) - IN8BIO, Inc. INAB.O :
* IN8BIO CONTINUES TO BUILD ON ITS CLINICAL AND REGULATORY
TEAM
WITH TWO KEY APPOINTMENTS
Source text for Eikon: ID:nGNX7FlwzX
Further company coverage: INAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IN8bio
See all newsIN8bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Biopharma firm IN8bio's Q2 net loss narrows as expenses decline
IN8bio Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: IN8BIO - Enters Capital On Demand Sales Agreement With Jonestrading For ATM Offering
IN8bio Q1 net loss narrows as R&D expenses fall